ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Urogen Pharma Ltd

Urogen Pharma Ltd (0XOD)

0.00
0.00
(0.00%)
Closed December 08 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
0.00
Ask
0.00
Volume
646
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.00
Open
-
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
30,866,000
Dividend Yield
-
PE Ratio
-3.71
Earnings Per Share (EPS)
-3.31
Revenue
82.71M
Net Profit
-102.24M

About Urogen Pharma Ltd

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Ra'anana, Center, Isr
Founded
-
Urogen Pharma Ltd is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0XOD. The last closing price for Urogen Pharma was $0. Over the last year, Urogen Pharma shares have traded in a share price range of $ 0.00 to $ 0.00.

Urogen Pharma currently has 30,866,000 shares outstanding. Urogen Pharma has a price to earnings ratio (PE ratio) of -3.71.

0XOD Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SCGLSealand Capital Galaxy Limited
2.10p
(90.91%)
18M
ARTLAlpha Real Trust Limited
198.00p
(55.29%)
70.11k
CLAICel Ai Plc
0.0775p
(26.63%)
101.96M
NEONeo Energy Metals Plc
1.20p
(26.32%)
76.6M
TOMTomco Energy Plc
0.0725p
(26.09%)
119.12M
SDXSdx Energy Plc
0.75p
(-60.53%)
5.2M
QUIZQuiz Plc
3.38p
(-36.82%)
1.88M
ZNTZentra Group Plc
2.50p
(-28.57%)
153.48k
ROCKRockfire Resources Plc
0.1275p
(-27.14%)
615.21M
SCESurface Transforms Plc
0.315p
(-26.74%)
98.64M
NTVONativo Resources Plc
0.0025p
(0.00%)
16.8B
SYMESupply@me Capital Plc
0.0032p
(6.67%)
2.21B
ORCPOracle Power Plc
0.036p
(-20.00%)
707.23M
ROCKRockfire Resources Plc
0.1275p
(-27.14%)
615.21M
TRPTower Resources Plc
0.0285p
(-1.72%)
385.17M

Discussion

View Full Feed
europa7 europa7 6 minutes ago
Citi, JP Morgan, others complete tokenization settlement trials
December 5, 2024
https://www.ledgerinsights.com/citi-wells-fargo-others-complete-tokenization-settlement-trials/

https://www.sifma.org/wp-content/uploads/2024/12/RSN-Technical-Report-FINAL.pdf

HBARUSD
tedpeele tedpeele 6 minutes ago
Moronic. The stock immediately went crazy Marco. Did you somehow miss that? That wasn’t because people said “oh look we are now in a commercialization process now that we’re in foundries that will make take years.

You’re looking back with 2020, but it does not mirror or reflect the me
LWLG
learningcurve2020 learningcurve2020 6 minutes ago
All of it is what happens when you have a therapy that shows maybe just a touch of efficacy but is far too expensive to commercialize.  Handsomely paid management  takes twenty years for a disease that kills almost all in under two years.  Runs multiple combo's trials in hopes something positive occ
NWBO
dalesio_98 dalesio_98 8 minutes ago
If I am not mistaken, Eno had options and not shares, they were out of the money.

Good luck to All!

I am not the only person who believes this occurred because of the ridiculously low upfront purchase price, noting that, last I looked, Eno still has his shares.
Resqnine Resqnine 9 minutes ago
Looking good, hopefully slow moves upwards 
EOSE
rocioyogi rocioyogi 10 minutes ago
I’m totally on the same page as you, but I’m thinking closer to .85 but would be so happy with a dollar now; doesn’t matter we’re sitting pretty just a matter of short short time
ELTP
rogers711 rogers711 10 minutes ago
But again it's all my opinion, if you want to call it unsubstantiated you aren't wrong but logically it's more accurate than this month like many are claiming...
RDGL
rogers711 rogers711 11 minutes ago
Agreed... I guess that was my point in my opinion is looking logically at the timeline and not running trials parallel to eachother it's going to take a bit longer than others feel it will...
RDGL
Jahvik Jahvik 11 minutes ago
I'm amazed at how much money I made!!
Well...I guess I was smart enough to buy in trips over and over and over and over and over

I only sold 50 million too lol
HMBL
StayHumble StayHumble 12 minutes ago
Xperts Must be💹 JUMBO SHORT💹 $SHMP $10 💹Markets Primed!
SHMP
rogers711 rogers711 13 minutes ago
It was just my opinion, but think logically, they haven't started trials yet in Southeast Asia or even announced a timeline and those will take months in my opinion... 
RDGL
KIPK KIPK 14 minutes ago
Had been floating on dualities of $0.0002 to $0.05-0.1.................
Outcome is reflection of efforts and creativity................
Years of innovations & crawling..... leading to fortition of efforts and flying......... imo
SRMX
rosemountbomber rosemountbomber 15 minutes ago
And who knows if after 10 years they still don't get it right.
AMRN
02opida 02opida 16 minutes ago
WASHINGTON—President-elect Donald Trump’s transition team is drafting several versions of his long-promised executive order to curtail automatic citizenship for anyone born in the U.S., according to people familiar with the matter, as his aides prepare for an expanded legal fight.

Tru
JOoa0ky JOoa0ky 18 minutes ago
Incorrect. $3.50 wall holds.
FNMA
02opida 02opida 18 minutes ago
Trump Prepares for Legal Fight Over His ‘Birthright Citizenship’ Curbs
02opida 02opida 20 minutes ago
OPEC+ extends its production cuts. MEG Energy wins a nod of approval from Fitch Ratings, while Kiwetinohk Energy has its eye on Alberta's data centre dreams. Kolibri Global cheers on its wells in Oklahoma, and LNG Energy puts itself up for sale
02opida 02opida 21 minutes ago
HII - HII Christens Virginia-Class Attack Submarine Arkansas (SSN 800)
HII
02opida 02opida 21 minutes ago
SNDX - Syndax Presents Positive Revuforj(TM) (revumenib) Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting
SNDX
Humbert Humbert 21 minutes ago
Should skyrocket shortly
BNCM
02opida 02opida 21 minutes ago
ADPT - Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ(TM) and Its Impact on Blood Cancer Treatment Decisions
closetokathy closetokathy 23 minutes ago
What exactly is Kate trying to accomplish? Does anyone know? I wish her luck as I have my eyes set on a Toyota Prius.
CEOS
hnbadger1 hnbadger1 24 minutes ago
http://cslide.ctimeetingtech.com/a

SAVXL wow, now famous Prof Timo Grimmer,
¡Technical University Munich, involved in the study, is presenting in Vienna, April AD/PD:
PHASE IIB/III ATTENTION-AD STUDY: OVER THREE YEARS OF CONTINUOUS TREATMENT WITH ORAL BLARCAMESINE CONTIN
AVXL

Your Recent History

Delayed Upgrade Clock